Skip to main content

Contraceptive Behavior

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Impact Therapeutics
Impact TherapeuticsChina - Shanghai
1 program
Self-Managed Contraceptive CareN/A1 trial
Active Trials
NCT07888296Recruiting2,736Est. May 2029

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
Impact TherapeuticsSelf-Managed Contraceptive Care

Clinical Trials (1)

Total enrollment: 2,736 patients across 1 trials

NCT07888296Impact TherapeuticsSelf-Managed Contraceptive Care

Impact of Self-Care Family Planning Services on Health and Development in South Sudan (Family Planning Impact Lab)

Start: Sep 2026Est. completion: May 20292,736 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 2,736 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.